Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 48 for “"Mevalonate"”.

  1. Variations in Mevalonate Pathway Flux in Human Cells with Familial Hypercholesterolemia

    The general metadata -- e.g., title, author, abstract, subject headings, etc. -- is publicly available, but access to the submitted files is restricted to UT Southwestern campus access and/or authorized UT Southwestern users.

    utswmed Repository record for Variations in Mevalonate Pathway Flux in Human Cells with Familial Hypercholesterolemia (opens in a new tab)

  2. Mevalonate metabolites contribute to granulocyte chemotaxis, cytokine production, and sepsis mortality

    Submission published under a 24 month embargo labeled 'Closed Access', the embargo will last until 2024-12-01

    uiuc Repository record for Mevalonate metabolites contribute to granulocyte chemotaxis, cytokine production, and sepsis mortality (opens in a new tab)

  3. Discovery of Enzymes Responsible for an Alternate Mevalonate Pathway in Haloferax volcanii

    … Radiolabeling experiments with acetate and mevalonate strongly implicate the mevalonate pathway in providing the isoprenoids for archaeal lipid biosynthesis. However, the enzymes responsible for mevalonate metabolism in archaea have remained either cryptic or poorly characterized. To …

    umkc Repository record for Discovery of Enzymes Responsible for an Alternate Mevalonate Pathway in Haloferax volcanii (opens in a new tab)

  4. Inhibition of enzymes from the non-mevalonate pathway using fragment-based approaches

    … against two essential target proteins in the non-mevalonate pathway (MEP), 1-deoxy-D-xylulose 5-phosphate synthase (DXS) from *D.radiodurans* and 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR) from *E.coli*. There have been only a handful of reports of small molecules developed to target …

    cambridge Repository record for Inhibition of enzymes from the non-mevalonate pathway using fragment-based approaches (opens in a new tab)

  5. The Role of Glutamine and Mevalonate Pathway In Affecting The Stemness and Viability of Glioblastoma Stem Cells

    … in the expression of genes related to the mevalonate pathway. We also found that simvastatin, an inhibitor of the mevalonate pathway, induced GBM stem cells death.</p> <p>This study showed mitochondria metabolic reprograming of GBM stem cells during differentiation. It also showed the …

    uthsc Repository record for The Role of Glutamine and Mevalonate Pathway In Affecting The Stemness and Viability of Glioblastoma Stem Cells (opens in a new tab)

  6. Functional and structural characterization of the mevalonate diphosphate decarboxylase and the isopentenyl diphosphate isomerase from Enterococcus faecalis

    … in <em>Enterococcus faecalis;</em> one is the mevalonate diphosphate decarboxylase (MDD) in the mevalonate pathway, and the other one is the isopentenyl diphosphate isomerase (IDI), which is downstream of MDD. Functional and structural studies on the mevalonate diphosphate decarboxylase from …

    purdue-thes Repository record for Functional and structural characterization of the mevalonate diphosphate decarboxylase and the isopentenyl diphosphate isomerase from Enterococcus faecalis (opens in a new tab)

  7. Association between Genetic Polymorphisms of Enzymes Involving Mevalonate Pathway(GGPS1 and FDPS) and Bone Mineral Density Response to Bisphosphonate Treatment

    Geranylgeranyl diphosphate synthase1(GGPS1)과 farnesyl diphosphate synthase(FDPS)는 골다공증 치료제인 질소 함유 비스포스포네이트가 억제하는 표적효소로, 환자마다 비스포스포네이트에 대한 반응이 달리 나타나는 이유는 이 표적효소들의 유전자 다형성에서 기인하는 부분이 있을 것으로 생각된다. 본 연구의 목적은 GGPS1, FDPS 유전자에서 한국인 고유의 유전자 다형성을 찾고, 이에 따라 비스포스포네이트 투여에 대한 반응에 차이가 있는지를 평가하는 것이다. 골다공증 외에 …

    ajou Repository record for Association between Genetic Polymorphisms of Enzymes Involving Mevalonate Pathway(GGPS1 and FDPS) and Bone Mineral Density Response to Bisphosphonate Treatment (opens in a new tab)

  8. Genetic Dissection of Heart Development in the Fruit Fly Drosophila Melanogaster

    … HMG-CoA Reductase, downstream enzymes in the mevalonate pathway, and G-protein Ggamma 1, which is geranylgeranylated, thus representing an endpoint of isoprenoid biosynthesis. These findings reveal a cardial cell-autonomous requirement of Ggamma 1 geranylgeranylation for heart formation and …

    utswmed Repository record for Genetic Dissection of Heart Development in the Fruit Fly Drosophila Melanogaster (opens in a new tab)

  9. On connections between metazoan cellular metabolism and cell size

    … biosynthesis and especially with inhibitions of mevalonate pathway. Systematic dissection of the mevalonate pathway revealed that protein geranylgeranylation is required for maintaining normal cell size and proliferation ratio. Geranylgeranylation of the recycling endosome regulating protein …

    dundee Repository record for On connections between metazoan cellular metabolism and cell size (opens in a new tab)

  10. Understanding and Harnessing the Structural Features that Govern HMG-CoA Reductase Activity

    … which catalyzes the reduction of HMG-CoA to mevalonate using two equivalents of the cofactor NAD(P)H, is part of the mevalonate pathway, found in all kingdoms of life. This pathway is at the heart of natural product biosynthesis constituting one of the obligate routes to producing the …

    bryn-mawr Repository record for Understanding and Harnessing the Structural Features that Govern HMG-CoA Reductase Activity (opens in a new tab)

  11. Impact of delta-tocotrienol on human melanoma cell proliferation

    The rate-limiting enzyme of the mevalonate pathway, 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, provides essential intermediates for the prenylation or dolichylation of growth-related proteins including nuclear Ras, nuclear lamins, and growth factor receptors. d-δ-tocotrienol, a …

    twu Repository record for Impact of delta-tocotrienol on human melanoma cell proliferation (opens in a new tab)

  12. The cloning and molecular regulation of rat 3-hydroxy-3-methylglutaryl coenzyme A reductase

    … reductase the key regulatory enzyme in the mevalonate pathway. The amino acid sequence of rat HMG-CoA reductase is highly homologous to hamster and human reductases. Noncoding regions of the reductase mRNAs are also highly conserved. Rat HMG-CoA reductase mRNA is initiated at a single …

    uiuc Repository record for The cloning and molecular regulation of rat 3-hydroxy-3-methylglutaryl coenzyme A reductase (opens in a new tab)

  13. Gain-of-Function Effects of Mutant p53 Explored Using a Three-Dimensional Culture Model of Breast Cancer

    … Genome-wide expression analysis identified the mevalonate pathway as significantly upregulated by mutant p53. Statins and sterol biosynthesis intermediates revealed that this pathway is both necessary and sufficient for the phenotypic effects of mutant p53 on mammary tissue architecture. We then …

    columbia-diss Repository record for Gain-of-Function Effects of Mutant p53 Explored Using a Three-Dimensional Culture Model of Breast Cancer (opens in a new tab)

  14. Role of Cholesterol 24-Hydroxylase in Hippocampal Long-Term Potentiation

    … on de novo cholesterol synthesis through the mevalonate pathway to meet the tissue's requirement for this essential lipid. A small amount of brain cholesterol is turned over daily in select neurons by cholesterol 24-hydroxylase, which catalyzes the production of the membrane-permeable …

    utswmed Repository record for Role of Cholesterol 24-Hydroxylase in Hippocampal Long-Term Potentiation (opens in a new tab)

  15. Gain-of-function and dominant-negative effects of distinct p53 mutations in lung tumours

    … to the type of p53 mutation. Upregulation of mevalonate pathway expression was observed only in R270H lung tumours and consequently R172H and R270H lung tumours displayed distinct sensitivities to simvastatin, a mevalonate pathway inhibitor widely used in the clinic. Furthermore, the …

    cambridge Repository record for Gain-of-function and dominant-negative effects of distinct p53 mutations in lung tumours (opens in a new tab)

  16. Investigating pathogen 4Fe-4S protein targets and cancer chemotherapies with bisphosphonate/diphosphate inhibitors

    … of the Methyl Erythritol Phosphate (MEP; non-mevalonate pathway) pathway in bacterial and parasitic human pathogens and inhibition of isoprenoid synthases in human cancers. For the development of antibacterials and antiparasitics, this research investigates the structure, function, and …

    uiuc Repository record for Investigating pathogen 4Fe-4S protein targets and cancer chemotherapies with bisphosphonate/diphosphate inhibitors (opens in a new tab)

  17. HMG-CoA Reductase Inhibitors Act Synergistically with UCN-01 Through RAS Inhibition

    … interfering with the rate-limiting step of the mevalonate pathway. Geranylgeranylpyrophosphate and farnesylpyrophosphate induce post-translational modifications in RAS that anchor the protein to the cell membrane so that it acts as a signal transducer to the nucleus, promoting cell proliferation.

    vcu Repository record for HMG-CoA Reductase Inhibitors Act Synergistically with UCN-01 Through RAS Inhibition (opens in a new tab)

Page 1 of 3